All comparisons
BMY vs MRK
Bristol-Myers Squibb Company vs Merck & Co., Inc.
Overview
BMYBristol-Myers Squibb Company
Score APrice
$60.57
Fair Value
$66.80
Upside
+10.3%
Convex Score
10/10
MRKMerck & Co., Inc.
Score APrice
$141.12
Fair Value
$170.74
Upside
+21.0%
Convex Score
10/10
Valuation
BMY
Bear$54.51
Base$89.34
Bull$138.15
Fair Value$66.80
MRK
Bear$127.01
Base$170.04
Bull$203.74
Fair Value$170.74
Quality
BMY
Grade
B
Score
80/100
Classification
Value
Rating
Score A
MRK
Grade
B
Score
83/100
Classification
Blue Chip
Rating
Score A
Company Info
| BMY | MRK | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Classification | Value | Blue Chip |
Verdict
MRK has better risk/reward
MRK: Higher upside potentialMRK: Better quality grade